270 High-throughput discovery of constitutive promoters to drive strong expression of next-generation gene circuits in CAR-NK and -T cells

270 High-throughput discovery of constitutive promoters to drive strong expression of next-generation gene circuits in CAR-NK and -T cells

Bibliographic Details
Main Authors:	Assen Roguev, Russell M Gordley, Timothy K Lu, Nicholas W Frankel, Ippolito I Caradonna, Tony Hua, Kanya Rajangam, Karen L Chu
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

257 NOT gate gene circuits expand the range of tumor-associated antigens addressable by CAR-NK and -T cell therapies
by: Derrick Lee, et al.
Published: (2023-11-01)

116 Development of logic gated CAR-NK cells for the treatment of solid tumors
by: Derrick Lee, et al.
Published: (2021-11-01)

CAR-NK cell therapy for glioblastoma: what to do next?
by: Qi Xiong, et al.
Published: (2023-06-01)

24 Small-molecule regulated safety switch for improved safety of CAR cell therapies in the brain
by: Marcus Gainer, et al.
Published: (2023-11-01)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
by: Kevin Pan, et al.
Published: (2022-03-01)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
by: Sergey Kulemzin, et al.
Published: (2021-11-01)

Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies
by: Adrien Krug, et al.
Published: (2021-12-01)

NK-SPECIFIC CAR DESIGN IMPROVES NK CYTOTOXICITY AGAINST TUMOR CELLS
by: JTC Azevedo, et al.
Published: (2021-10-01)

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
by: Erica L. Heipertz, et al.
Published: (2021-12-01)

The research significance of concomitant use of CAR-CD138-NK and CAR-CD19-NK to target multiple myelomas
by: Songbo Zhao, et al.
Published: (2018-07-01)

Aoife O'Donoghue, Constitutionalism in Global Constitutionalisation, Cambridge University Press, 2014., p. 270
by: Mia Bašić
Published: (2016-01-01)

Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy
by: Marisa K. Kilgour, et al.
Published: (2023-05-01)

CAR-NK Cells in the Treatment of Solid Tumors
by: Ewa Wrona, et al.
Published: (2021-05-01)

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
by: Xinyu Wu, et al.
Published: (2022-12-01)

Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer
by: Alexander Sebastian Franzén, et al.
Published: (2024-01-01)

Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer
by: Martin J. Raftery, et al.
Published: (2023-05-01)

CAR-T: What Is Next?
by: Yi-Ju Chen, et al.
Published: (2023-01-01)

CRISPR, CAR-T, and NK: Current applications and future perspectives
by: Mohadeseh Khoshandam, et al.
Published: (2024-07-01)

Breakthrough of solid tumor treatment: CAR-NK immunotherapy
by: Wenkang Wang, et al.
Published: (2024-01-01)

Outsmarting trogocytosis to boost CAR NK/T cell therapy
by: Faezeh Ramezani, et al.
Published: (2023-11-01)

Current Progress of CAR-NK Therapy in Cancer Treatment
by: Zhaojun Pang, et al.
Published: (2022-09-01)

IPSC-derived CAR-NK cells for cancer immunotherapy
by: Xiaotong Lin, et al.
Published: (2023-09-01)

Biomarkers as targets for CAR-T/NK cell therapy in AML
by: Ruonan Shao, et al.
Published: (2023-06-01)

OPTIMIZING INTRACELLULAR SIGNALING DOMAINS FOR CAR-NK CELLS
by: J.T.C. Azevedo, et al.
Published: (2020-11-01)

The Advances and Challenges of CAR-NK Cells for Tumor Immunotherapy
by: Ye Ziyun A.
Published: (2019-01-01)

Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing
by: Tiziano Ingegnere, et al.
Published: (2019-04-01)

Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies
by: Rana Mhaidly, et al.
Published: (2020-07-01)

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
by: Lara Herrera, et al.
Published: (2021-10-01)

6.270 course notes
by: Allen, Michael S. (Michael Scott), 1975-
Published: (2013)

KFE 270-4 & KFP 270-4 - MATEMATIK UNTUK KIMIA OKT. 1987-88
by: PPSK, Pusat Pengajian Sains Kimia
Published: (1988)

From CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies
by: Hui Lu, et al.
Published: (2021-08-01)

Preclinical and clinical studies of CAR-NK-cell therapies for malignancies
by: Hongwen Li, et al.
Published: (2022-10-01)

CAR-NK cells: A promising cellular immunotherapy for cancer
by: Xie, Guozhu, et al.
Published: (2022)

CAR-NK cells: A promising cellular immunotherapy for cancer
by: Xie, Guozhu, et al.
Published: (2021)

CAR-NK cell therapeutics for hematologic malignancies: hope is on the horizon
by: Kai-lin Xu, et al.
Published: (2019-10-01)

CAR-NK cells for cancer immunotherapy: from bench to bedside
by: Leisheng Zhang, et al.
Published: (2022-03-01)

CAR-NK cells: A promising cellular immunotherapy for cancer
by: Guozhu Xie, et al.
Published: (2020-09-01)

Overcoming tumor resistance mechanisms in CAR-NK cell therapy
by: Antonio Valeri, et al.
Published: (2022-08-01)

NON-VIRAL ENGINEERING OF CAR-NK CELLS FOR CANCER IMMUNOTHERAPY
by: K.R.S. Gomes, et al.
Published: (2020-11-01)

CAR-NK Cells: From Natural Basis to Design for Kill
by: Muhammad Babar Khawar, et al.
Published: (2021-12-01)